市場調查報告書
商品編碼
1284292
2028 年實驗室冷凍機市場預測——按產品類型、最終用戶和地區分列的全球分析Laboratory Freezers Market Forecasts to 2028 - Global Analysis By Product Type, End Users and By Geography |
根據 Stratistics MRC 的數據,2022 年全球實驗冷凍機市場規模將達到 48.3 億美元,預計到 2028 年將達到 74.6 億美元。預計將以 7.5% 的複合年增長率增長。
實驗室冷凍機是一種精心構造的實驗設備,具有隔熱隔間和熱泵,可將熱量從設備內部傳遞到周圍環境。 根據被冷凍的材料,冷凍室的內部被冷卻到低於水的冰點的溫度。 實驗室冷凍機是血庫、學術機構、製藥公司和生物技術公司的常用設備,用於儲存血液、組織、血清和疫苗樣本等各種生物製品。 用於測試和實驗的生物樣本可以儲存在這個冰箱裡。
根據美國能源部 (DOE) 的數據,美國實驗室冷凍機每年消耗約 30 億千瓦時的電力,約占美國所有電力消耗的 2%。
對血液和血液成分的需求不斷增加,以支持輸血和癌症治療。
全球對血液和血液成分的需求正在增長。 據美國紅十字會稱,僅在美國每年就有大約 2100 萬份血液成分被輸注。 美國癌症協會估計,2020 年美國將有 180 萬例癌症新病例。 據說接受癌症手術的患者和患有白血病和淋巴瘤等血癌的患者對血液和血液成分的需求很高。 此外,世衛組織報告稱,從 2013 年到 2018 年,全球自願和無償獻血增加了 780 萬次。 由於全球獻血量增加以及對血液和血液製品的需求增加,預計對血庫實驗室冷凍機和冰箱的需求將增加。
醫院、實驗室和血庫對生物醫學樣本的低溫保存投入了大量資金。 超低溫冰箱的平均成本在 10,000 美元到 25,000 美元之間,這讓小型血庫、醫院和實驗室望塵莫及。 再生醫療設備的價格通常保持在新設備價格的50%至60%左右。 許多新興和欠發達國家的基礎設施公共衛生資金不足,限制了在其醫療保健系統中採用技術先進的醫療設備。。 在預測期內,對翻新實驗室冷凍機和冰箱的高需求將在一定程度上抑制全球實驗室冷凍機市場的增長。
COVID-19 大流行已將注意力集中在針對新發傳染病的疫苗開發上。 由於對疫苗開發的關注和投資增加,未來幾年疫苗的臨床研究試驗將會增加。 大多數疫苗在研發和分銷過程中需要低溫儲存,這將推動實驗室冷凍機和冰箱的市場增長。 因此,增加投資並專注於針對新發傳染病的疫苗開發,將為未來幾年實驗冷凍市場的參與者提供機會。
一些診所、實驗室、血庫和藥房缺乏正確使用醫療和實驗室冰箱的知識。 小型藥店和血庫可能看不到使用某些冰箱儲存某些標本的好處。 家用冰箱不能為儲存 DNA 測試樣本、血液、血液成分等提供最佳溫度條件。 家用冰箱是為了提高效率和妥協溫度精度而設計的,以允許一些溫度波動。 這最大限度地減少了冷卻儲藏室所需的壓縮機運行時間和頻率。 然而,精確的溫度控制、可靠性和存儲容量是實驗室冷凍機設計的關鍵因素。 次優存儲會導致樣品污染和失真的結果。 因此,缺乏對醫學標本的正確儲存方法以及實驗室冰箱和冰櫃的維護和管理的知識可能會阻礙該市場的發展。
COVID-19 疫情對實驗室冰箱市場產生了非常積極的長期影響。 由於封鎖和檢疫措施,實驗室冷凍機市場最初在 2020 年初出現下滑。 但隨著疾病在世界範圍內蔓延,負責處理 SARS-CoV-2 樣本、試劑和疫苗的實驗室以及 COVID-19 檢測點和處理設施的數量猛增。 因此,越來越需要實驗室冰箱、冰櫃和超低溫冰櫃來支持樣品處理、測試和疫苗開發實驗室。
在預測期內,製冷機部分預計將佔最大的收入份額。 Ultra Freezers 是血庫、輸血設施、醫院、工業實驗室、醫學研究機構等的理想選擇,是工業和科學研究的完美選擇。 能夠在低溫下長時間儲存樣品是超速冰箱的一個基本優勢,因此參考應用通常涉及非常脆弱的樣品。 這些因素正在推動這一領域的收入增長。
預計在預測期內,血庫部門的收入複合年增長率將顯著提高。 這是由於鐮狀細胞性貧血、血友病和血癌的流行導致對全血和血液成分的需求增加,以及生物製藥製造商需要血漿用於血漿分離技術。據認為, 血庫將收到的樣本分成不同的部分,以便最有效地使用它來滿足患者的需求。 血庫聘請合格的實驗室專家團隊快速準確地處理樣本。 與忙碌的醫院同事形成鮮明對比的是,他們通常在平靜的環境中匿名工作。 這些因素增加了該細分市場的銷售額。
北美擁有最大的實驗室冷凍機市場份額。 美國和加拿大的高醫療保健成本,以及製藥和生物技術研發支出的增加,是該地區市場份額很大的原因。 此外,該地區實驗室冷凍機和冰箱製造商的激增也為市場增長做出了重大貢獻。
預計亞太市場在預測期內的收入複合年增長率最高。 這種增長是由政府舉措的增加、許多本地企業銷售品牌產品的存在、幹細胞庫的細胞採集和冷凍保存頻率增加以及資金狀況良好等推動的。 例如,2022 年 2 月,公司宣佈在公司位於印度浦那的第一個工業園區開設海爾新的深冷櫃生產設施。 海爾是全球家電和消費電子產品的市場領導者。 通過此舉,海爾加大了對印度中央政府“印度製造”計劃的支持力度,該計劃旨在生產滿足印度消費者需求的高端產品,促進國內製造業的增長。 該投資還將加強海爾在印度的地位,並提高其優質深冷設備的年生產能力。
2022 年 1 月,生命科學行業溫控供應鏈解決方案的全球領導者 Cryoport, Inc. 與 Cell Matters, S.A 達成戰略合作,以支持自體和同種異體細胞療法,宣布它將提供持續使用的白細胞衍生療法的端到端冷凍保存服務。 兩家公司將共同製定一項商業戰略,以推廣這些服務。
2021 年 3 月,超低溫 (ULT) 冰箱的先驅開發商 Sterling UltraCold, Inc. 將結合其專業知識,為生物製藥研究和生命科學客戶開發個性化產品。宣布已達成協議與 BioLife Solutions 合併以擴大規模的最終協議。 交易於 2021 年第二季度初完成後,BioLife 希望在俄亥俄州雅典保留 Stirling Ultracold 品牌和現有團隊,同時照常為現有客戶和合作夥伴提供業務。
2021 年 10 月,EIN 發表了一篇關於實驗室冷凍機市場的文章,該文章摘自 TBRC 的全球實驗室冷凍機市場報告。 TBRC 的全球實驗室冷凍機市場報告包括 -20°C 至 -40°C、-40°C 至 -80°C、-80°C 以下、生物銀行和血庫以及藥品。
According to Stratistics MRC, the Global Laboratory Freezers Market is accounted for $4.83 billion in 2022 and is expected to reach $7.46 billion by 2028 growing at a CAGR of 7.5% during the forecast period. A laboratory freezer is a carefully constructed piece of lab equipment with a thermally insulated compartment and a heat pump that transfers heat from the interior of the device to its surroundings. Depending on the substance being frozen, the interior of the freezer is cooled to a temperature that is at or much below the freezing point of water. For the preservation of various biological products like blood, tissues, serum, vaccine samples, and so forth, laboratory freezers are a common piece of equipment in blood banks, academic institutions, pharmaceutical companies, and biotechnology businesses. The biological samples that are being examined and used in experiments can be kept in the freezers.
According to the U.S. Department of Energy (DOE), laboratory freezers use approximately 3 billion kWh of electricity annually in the U.S., which is equivalent to approximately 2% of all electricity consumed in the country.
Blood and blood components are in greater demand for transfusions and to support cancer treatment.
The demand for blood and blood components is growing on a global scale. Approximately 21 million blood components are transfused annually in the US alone, according to the American National Red Cross. The American Cancer Society estimates that there will be 1.8 million new cancer cases in the US in 2020. Patients undergoing cancer surgery and those with blood cancers like leukemia and lymphoma have a high need for blood and blood components. Additionally, the WHO reported that from 2013 to 2018, there was an increase of 7.8 million voluntary unpaid blood donations worldwide. The demand for lab freezers and refrigerators in blood banks will rise as a result of the rise in global blood donation and the demand for blood and blood products.
Hospitals, laboratories, and blood banks all make significant capital expenditures for the cold storage of biomedical samples. Since the average cost of an ultra-low-temperature freezer is between $10,000 and $25,000, smaller blood banks, hospitals, and laboratories cannot afford them. Refurbished medical equipment typically costs between 50% and 60% less than brand-new equipment. The adoption of technologically advanced medical devices in healthcare systems throughout these countries is constrained by the inadequate public healthcare expenditure for infrastructure improvement in many emerging and underdeveloped countries. During the forecast period, the high demand for refurbished lab freezers and refrigerators will restrain the growth of the global laboratory freezer market to some extent.
Due to the COVID-19 pandemic, there has been a greater focus on developing vaccines for infectious diseases that are just starting to emerge. The growth of clinical research trials for vaccines in the upcoming years will be aided by the increased focus on and investments in vaccine development. As most vaccines must be stored at low temperatures during the development and distribution processes, this would in turn spur market growth for lab freezers and refrigerators. Therefore, players in the laboratory freezer market will have an opportunity in the years to come as a result of the growing investments in and attention to vaccine development for emerging infectious diseases.
There are some clinics, laboratories, blood banks, and pharmacies where there is a lack of knowledge regarding how to use medical and lab refrigerators properly. Small chemist shops or blood bank providers might not be aware of the advantages of using particular refrigerators to store particular specimens. Domestic refrigerators don't offer the best temperature conditions for preserving things like DNA test samples, blood, and blood components. Domestic refrigerators are made with efficiency in mind, making some compromises in terms of temperature accuracy to allow for some temperature variability. This minimizes the amount of time and frequency the compressor needs to run to cool the storage chamber. However, precise temperature control, dependability, and storage capacity are major factors in the design of lab freezers. The samples could become contaminated, and the results could be skewed if they are not stored in the best possible conditions. As a result, the development of this market may be hindered by a lack of knowledge regarding the proper storage of medical specimens and the upkeep of laboratory refrigerators and freezers.
The COVID-19 pandemic has had a very positive long-term effect on the market for laboratory freezers. The market for lab freezers and refrigerators initially experienced a decline in early 2020 as a result of lockdowns and quarantine measures. However, as the illness spread around the globe, there was a sharp increase in the number of labs, COVID-19 testing locations, and processing facilities in charge of handling SARS-CoV-2 samples, reagents, and vaccines. The need for laboratory refrigerators, freezers, and ultra-low-temperature freezers to support sample processing, testing, and vaccine development labs consequently increased.
During the forecast period, the freezer segment is anticipated to contribute the largest revenue share. The best option for both industry and scientific research is an ultra-freezer, which is ideal for blood banks, transfusion facilities, hospitals, industrial research labs, and medical research institutions. The ability to store samples at low temperatures for extended periods of time is the fundamental benefit of an ultra-freezer; as a result, reference applications often involve very sensitive samples. The segment's revenue growth is being driven by these elements.
The segment of blood banks is anticipated to experience a significantly rapid revenue CAGR during the forecast period, which can be attributed to the increasing demand for whole blood and blood components as a result of the prevalence of sickle cell anemia, hemophilia, and blood cancer, as well as the need for plasma from biopharmaceutical producers for use in plasma fractionation techniques. So that they can be used most effectively based on the needs of the patient, blood banks divide the samples they receive into a variety of parts. To process samples quickly and precisely, blood banks employ teams of qualified laboratory experts. They work in anonymity and under generally calm circumstances, in stark contrast to their colleagues in busy hospitals. The segment's revenue is increasing due to these factors.
North America held the largest market share for laboratory freezers. The high healthcare costs in the US and Canada, as well as the rising R&D expenditure on pharmaceuticals and biotechnology in this region, are to blame for the large share of this regional segment. The proliferation of laboratory freezer and refrigerator producers in the area also significantly contributes to the market's expansion.
The market in Asia Pacific is anticipated to experience the highest revenue CAGR over the course of the forecast period. This growth is attributed to increased government initiatives, the presence of numerous local businesses that sell branded goods, the increasing frequency of cell collection and cryopreservation for stem cell banks, and favorable funding conditions. For instance, the opening of Haier's new deep freezer production facility at its first industrial park in Pune, India, was announced in February 2022. Haier is the market leader in consumer electronics and home appliances worldwide. With this action, Haier has strengthened its support for the 'Make in India' program of the Indian Central Government, which seeks to promote domestic manufacturing by producing high-end goods to satisfy Indian consumers' needs. The investment would also strengthen Haier's position in India and increase its capacity to produce high-quality deep freezer equipment annually.
Some of the key players in Laboratory Freezers market include Agilent Technologies, Inc , Antylia Scientific, ARCTIKO A/S, Arxspan a Bruker Company, Autoscribe Informatics., B Medical Systems, BioLife Solutions, Inc, Cerner Corporation, Changhong Meiling Co. Ltd., Dassault Systemes, Glen Dimplex Medical Appliances, KW Apparecchi Scientifici SRL, LabVantage Solutions Inc., McKesson Corporation, PHC Holdings Corporation, Philipp Kirsch GmbH, Refrigerated Solutions Group, Scientific Equipment Repair, So-Low Environmental Equipment Co. Ltd., Standex International Corporation, Stericox India Private Limited, Thermo Fisher Scientific, Inc and Vestfrost Solutions A/S.
In January 2022, Cryoport, Inc., which is a worldwide leader in temperature-controlled supply chain solutions for the life sciences industry, announced a strategic collaboration with Cell Matters, S.A. to provide end-to-end cryopreservation services for leukapheresis-derived therapies continuing to support both autologous and allogeneic cell therapies. The businesses will work together to devise a commercial strategy for promoting these services.
In March 2021, Stirling Ultracold, which is a privately owned ingenious development company of Ultra-low Temperature (ULT) freezers, announced a definitive agreement to merge with BioLife Solutions in order to combine expert knowledge and widen individual product offerings for biopharma research as well as life science clients. Following the closure of this deal in the early second quarter of 2021, BioLife wants to preserve the Stirling Ultracold brand and current team in Athens, Ohio - indicating business-as-usual for existing customers and partners.
In October 2021, EIN released an article on the laboratory freezer market, sourced from TBRC's Global Laboratory Freezers Market report. TBRC global laboratory freezers market report includes -20°C to -40°C, -40°C to -80°C, less than -80°C, bio-banks and blood banks, pharmaceutical.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.